Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies-Reference-Cited by-同舟云学术

Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies

Published:2016-11-03 Issue:11 Volume:11 Page:e0165811
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Schlesinger Sabrina,Sonntag Svenja R.,Lieb Wolfgang,Maas Renke

Funder

DFG

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference99 articles.

1. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1);J Strobel;Amino Acids,2013

2. Pharmacology and clinical pharmacology of methylarginines used as inhibitors of nitric oxide synthases;A Kittel;Curr Pharm Des,2014

3. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure;P Vallance;Lancet,1992

4. Disruption of methylarginine metabolism impairs vascular homeostasis;J Leiper;Nat Med,2007

5. Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine;J Jacobi;Am J Pathol,2010

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Quantitative Plasma Metabolomics Identifies Metabolite Signatures that Distinguish Heart Failure with Reduced and Preserved Ejection Fraction;2024-07-25

2. Redefining the biological and pathophysiological role of dimethylarginine dimethylaminohydrolase 2;Trends in Molecular Medicine;2024-06

3. Metabolomics and Cardiovascular Risk in Patients with Heart Failure: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2024-05-23

4. Lipoprotein dysfunction in patients with chronic kidney disease (CKD). Pathogenesis and treatment of CKD dyslipidemia (literature review);Nephrology (Saint-Petersburg);2024-03-03

5. Prognostic implications of the arginine metabolism in patients at nutritional risk: A secondary analysis of the randomized EFFORT trial;Clinical Nutrition;2024-03